Joined January 2016
InterAx and @Boehringer take first steps towards collaborating to unlock orphan targets leveraging InterAx AI driven discovery platform. Collaborative efforts aim to accelerate and improve the prediction of first in class small molecule agonists for a challenging orphan GPCR 💊
2
4
@InterAxBiotech is pleased to announce that Carola Weiss has joined the company as VP Business Development. Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical industry.
1
InterA successfully completed its EU #H2020 project 4 months ahead of schedule. The newly developed discovery platform combines for the first time classical pharmacology, computational methods, systems biology and AI to revolutionise 💊 drug discovery. lnkd.in/dnH2Q9JK
1
1
We are happy to announce that Prof. Dr. Ruedi Aebersold has joined the company Scientific Advisory Board (SAB) as a member. interaxbiotech.com/apr-2021/ #systemsbiology #artificialintelligence #drugdiscovery #gpcr #ethzurich #spinoff #PSI #eicaccelerator #h2020 #eufunding
1
2
If you want to learn about analysis of complex GPCR signaling data with #systemsbiology - see the talk of Susanne Roth at GM of the European Research Network on Signal Transduction #ERNEST. Today at 2-2:30 PM CET -> Register for free lnkd.in/diygMCp #Horizon2020 #EU_EIC
2
3
European Research Network on Signal Transduction #ERNEST - Programme announced! Our CEO Aurélien Rizk is talking anout Integrating systems biology and #artificialitellegence to analyze and predict #GPCR signaling. April 12th, 14.00-14:30. Save the date! ernestcostaction.wixsite.com…
2
4
InterAx and Prof. @JanaSelent from the @hospitaldelmar (IMIM) collaborates to identify antiviral drugs COVID-19 treatment by combining virtual screening of a 3D-structural database and assessing the effectiveness of these compounds to block viral entry. interaxbiotech.com/apr-2020/
1
2
Happy to be one of the 10 Swiss Biotech Startups to watch in 2020! Thanks @venturelab_ch to always keep a very close eye on the Swiss startup ecosystem, analyse trends and publish your reports. lnkd.in/dignhKt
2
3
InterAx Biotech AG and GPCR Therapeutics Inc. collaborate for the identification of compounds with superior biological properties targeting GPCR heteromers using the InterAx systems biology platform. lnkd.in/dDzKPgb #biotech #platform #systemsbiology #GPCR
1
2
We are at the BioEurope! Rolf Rolli and Yaroslav Nikolaev are proudly representing InterAx in Hamburg this week. @EBDgroup #BIOEurope @SwissBiotech #SwissPavilion, Hall B7, booth 158
1
2
We are very proud to announce that the #EU_EIC awarded InterAx with #horizon2020 SME Instrument Phase 2 for the integration of #machinelearning into the InterAx #systemsbiology platform for #drugdiscovery interaxbiotech.com/News_09.1…
Great time at the @BIOConvention in #Philly raising awareness about our #systemsbiology platform - better in-vitro to in-vivo translation! Thanks to @SGE @SwissBiotech @_Innosuisse for your the support!
1
4
Dr. Martin Ostermaier, InterAx CEO, is presenting today an overview of our intelligent #drugdiscovery platform at the 3rd Drug Discovery Summit in Barcelona #systemsbiology #GPCRpharmacology #CellSignaling
1
2
InterAx Biotech AG announced today that it has entered an agreement with @Lundbeck A/S to enable the in-depth characterization of drug candidates using the proprietary InterAx systems biology platform. interaxbiotech.com/News-Lund… #biotech #technology #platform #systemsbiology
Martin is presenting @InterAxBiotech at #BioEuropeSpring today at 15.00 in the Schubert 4 room on level 1. Don't miss it! #Vienna @EBDgroup
3
Hello from #BioEuropeSpring! You can meet our CEO Martin Ostermaier and our CSO Maria Waldhoer until Wednesday in #Vienna. Martin will present @InterAxBiotech in the next generation track tomorrow Tue 26 at 15.00 in Schubert 4 room on level 1 @EBDgroup
@InterAxBiotech announces today that it received the Seal of Excellence by the European Commission, as the institution managing Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020 for its Disruptive GPCR Lead Discovery Platform
1
1
InterAx closed a financing round of CHF 3 million. The round was led by Falcon III Ventures and @investiere. The new funds will be used to accelerate commercialization of the technology platform. InterAx also welcomes Dr. Bettina Ernst as a new member of the board of directors.
3